Solid pavestones are needed to pave a solid way to success Haidong Dong Editorial 27 November 2019 Pages: 1 - 1
Mechanisms of immune evasion in bladder cancer Paul L. CrispenSergei Kusmartsev Review Open access 06 December 2019 Pages: 3 - 14
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody Ryota ShibakiShuji MurakamiYuichiro Ohe Original Article 19 November 2019 Pages: 15 - 22
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers Tomohiro KikuchiKosaku MimuraKoji Kono Original Article 26 November 2019 Pages: 23 - 32
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer Liju ZongYuncan ZhouYang Xiang Original Article Open access 28 November 2019 Pages: 33 - 42
Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells Yeni RomeroRandi WiseAnna Zolkiewska Original Article 03 December 2019 Pages: 43 - 55
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression Richard KlarSven MichelFrank Jaschinski Original Article 04 December 2019 Pages: 57 - 67
Interleukin-38 in colorectal cancer: a potential role in precision medicine Feier ChenFeng ZhangKun Tao Original Article 30 November 2019 Pages: 69 - 79
GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma Aida RashidiJason MiskaMaciej S. Lesniak Original Article 16 December 2019 Pages: 81 - 94
Tailoring early-phase clinical trial design to address multiple research objectives Nolan A. WagesCraig L. Slingluff Jr.Gina R. Petroni Original Article 05 December 2019 Pages: 95 - 102
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1 Nuray ErinSayra DilmaçReginald M. Gorczynski Original Article 06 December 2019 Pages: 103 - 114
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment Chunyan YuXiulong NiuWeimin Deng Original Article 04 December 2019 Pages: 115 - 126
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer Yuki OzakiSatoshi MutoHiroyuki Suzuki Original Article 06 December 2019 Pages: 127 - 134
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models Rui ZhangFengjiao YuanLi Yang Original Article Open access 05 December 2019 Pages: 135 - 145
Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer Johanna WaidhauserAnja SchuhAndreas Rank Original Article 03 January 2020 Pages: 147 - 157
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy Nadia MensaliMarit Renée MyhreElse Marit Inderberg Correction Open access 27 November 2019 Pages: 159 - 161